Articles Tagged With: SSRI
-
Using Genetic Testing to Improve Patient Health
To begin shifting from a reactive to a more proactive approach to healthcare, researchers and providers are taking notice of genetic testing and its benefits in making medical decisions.
-
Premenstrual Anxiety, Mood Swings Are Common Among Women Worldwide
New research shows that women worldwide experience unpleasant premenstrual symtoms, including food cravings (85%) and mood swings or anxiety (64%). Other reported symptoms included fatigue, irritability, bloating, and breast tenderness.
-
Treating Anxiety Disorders in Primary Care
Anxiety disorders are the most prevalent mental health problem worldwide. Collectively, these disorders are at the core of 20% of primary care visits in the United States. This article reviews in-depth several common disorders of anxiety — GAD, PD, and SAnD — with a focus on diagnosis and treatment relevant to the primary care provider.
-
The Association Between SSRIs and Congenital Anomalies
In this synthesis involving 15 meta-analytic studies, four studies demonstrated an association between paroxetine use during pregnancy and increased risk of major congenital anomalies (relative risk [RR], 1.18 [95% confidence interval (CI), 1.05, 1.32] to 1.29 [95% CI, 1.11-1.49]). For all selective serotonin reuptake inhibitors (SSRIs), the RR for major anomalies (1.10 [95% CI, 1.03, 1.16] to 1.27 [95% CI, 1.09, 1.47]) and cardiac defects (1.06 [95% CI, 0.94, 1.18] to 1.36 [95% CI, 0.61, 3.04]) were increased. This meta-analysis suggests an increased risk of cardiac and major anomalies with SSRI use, but the results should be interpreted with caution, since all included studies were meta-analyses of retrospective cohort studies.